ALA a 100 million market cap and in preclinical stages is a 100 million market cap with NYR having a significantly larger unmet market at a 19 million market cap with phase 1 cohort results due 3 weeks away with all preclinical data showing significant results. Just plain stupid. NYR will be trading at a 60-120 million market cap on safety on a 60 billion dollar unmet market.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.03M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1642 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 682527 | 2 |
View Market Depth
| Last trade - 07.10am 01/08/2025 (20 minute delay) ? |
| NYR (ASX) Chart |
Day chart unavailable